Identification of potential multitarget antimalarial drugs.
暂无分享，去创建一个
[1] Ram Samudrala,et al. Prediction of HIV-1 Protease Inhibitor Resistance using a Protein–Inhibitor Flexible Docking Approach , 2005, Antiviral therapy.
[2] S. Gulnik,et al. Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum. , 2003, Journal of molecular biology.
[3] Péter Csermely,et al. The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.
[4] Yongyuth Yuthavong,et al. Insights into antifolate resistance from malarial DHFR-TS structures , 2003, Nature Structural Biology.
[5] V. A. Stewart,et al. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. , 2005, Vaccine.
[6] Dinesh Gupta,et al. Distribution of proline-rich (PxxP) motifs in distinct proteomes: functional and therapeutic implications for malaria and tuberculosis. , 2004, Protein engineering, design & selection : PEDS.
[7] K. Thimasarn,et al. Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand. , 1998, Bulletin of the World Health Organization.
[8] J. Baird,et al. Effectiveness of antimalarial drugs. , 2005, The New England journal of medicine.
[9] C. Long,et al. Malaria vaccines: multiple targets. , 1994, Science.